SELLAS Life Sciences (SLS) Other Gross PP&E Adjustments (2011 - 2026)

SELLAS Life Sciences (SLS) reported Other Gross PP&E Adjustments of -$1.1 million for Q1 2026, down 4.38% year-over-year from -$1.1 million in Q1 2025, and up 4.86% on a QoQ basis from -$1.2 million in Q4 2025.

SELLAS Life Sciences (SLS) has 16 years of Other Gross PP&E Adjustments data on file, last reported at -$1.1 million in Q1 2026.

  • Quarterly Other Gross PP&E Adjustments fell 4.38% year-over-year to -$1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.1 million (down 4.38% YoY) and the FY2025 annual result came in at -$1.2 million, up 25.47% from the prior year.
  • Other Gross PP&E Adjustments improved to -$1.1 million in Q1 2026 per SLS's latest filing, from -$1.2 million in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at -$756000.0 in Q2 2024 and bottomed at -$1.6 million in Q1 2023.
  • The 5-year median for Other Gross PP&E Adjustments is -$1.1 million (2026), against an average of -$1.1 million.
  • The widest annual swing landed in 2022, when Other Gross PP&E Adjustments sank 44.42%; it then rose 28.06% in 2025.
  • Tracing SLS's Other Gross PP&E Adjustments over 5 years: stood at -$1.2 million in 2022, then retreated by 21.37% to -$1.5 million in 2023, then fell by 5.17% to -$1.5 million in 2024, then rose by 25.47% to -$1.2 million in 2025, then climbed by 4.86% to -$1.1 million in 2026.
  • Per Business Quant, the three latest SLS Other Gross PP&E Adjustments figures stand at -$1.1 million (Q1 2026), -$1.2 million (Q4 2025), and -$780000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Gross PP&E Adjustments (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -83,048.00
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -60,691.22
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -285.20 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -892,000.00
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn -1.69 Bn
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn -189.30 Mn
10 SELLAS Life Sciences 1.61 Bn 1.61 Bn - -1.10 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -1.10 Mn
Mar 31, 2026 -1.10 Mn
Dec 31, 2025 -1.15 Mn
Dec 31, 2025 -1.15 Mn
Sep 30, 2025 -780,000.00
Sep 30, 2025 -780,000.00
Jun 30, 2025 -948,000.00
Jun 30, 2025 -948,000.00
Mar 31, 2025 -1.05 Mn
Mar 31, 2025 -1.05 Mn
Dec 31, 2024 -1.55 Mn
Dec 31, 2024 -1.55 Mn
Sep 30, 2024 -829,000.00
Sep 30, 2024 -829,000.00
Jun 30, 2024 -756,000.00
Jun 30, 2024 -756,000.00
Mar 31, 2024 -1.46 Mn
Mar 31, 2024 -1.46 Mn
Dec 31, 2023 -1.47 Mn
Dec 31, 2023 -1.47 Mn
Sep 30, 2023 -896,000.00
Sep 30, 2023 -896,000.00
Jun 30, 2023 -898,000.00
Jun 30, 2023 -898,000.00
Mar 31, 2023 -1.61 Mn
Mar 31, 2023 -1.61 Mn
Dec 31, 2022 -1.21 Mn
Dec 31, 2022 -1.21 Mn
Sep 30, 2022 -1.16 Mn
Sep 30, 2022 -1.16 Mn
Jun 30, 2022 -1.08 Mn
Jun 30, 2022 -1.08 Mn
Mar 31, 2022 -1.39 Mn
Mar 31, 2022 -1.39 Mn
Dec 31, 2021 -888,000.00
Dec 31, 2021 -888,000.00
Sep 30, 2021 -806,000.00
Sep 30, 2021 -806,000.00
Jun 30, 2021 -961,000.00
Jun 30, 2021 -961,000.00
Mar 31, 2021 -1.15 Mn
Mar 31, 2021 -1.15 Mn
Dec 31, 2020 -1.17 Mn
Dec 31, 2020 -1.17 Mn
Sep 30, 2020 -1.29 Mn
Sep 30, 2020 -1.29 Mn
Jun 30, 2020 -1.28 Mn
Jun 30, 2020 -1.28 Mn
Mar 31, 2020 -257,000.00
Mar 31, 2020 -257,000.00
Dec 31, 2019 -2.28 Mn
Dec 31, 2019 -2.28 Mn
Sep 30, 2019 -634,000.00
Sep 30, 2019 -634,000.00
Jun 30, 2019 -390,000.00
Jun 30, 2019 -390,000.00
Mar 31, 2019 -471,000.00
Mar 31, 2019 -471,000.00
Dec 31, 2018 -2.22 Mn
Dec 31, 2018 -2.22 Mn
Dec 31, 2017 -2.55 Mn
Dec 31, 2017 -2.55 Mn
Dec 31, 2016 -1.08 Mn
Dec 31, 2016 -1.08 Mn
Dec 31, 2015 -5.05 Mn
Dec 31, 2015 -5.05 Mn
Dec 31, 2014 -4.68 Mn
Dec 31, 2014 -4.68 Mn
Dec 31, 2013 -8.32 Mn
Dec 31, 2013 -8.32 Mn
Dec 31, 2012 -7.94 Mn
Dec 31, 2012 -7.94 Mn
Dec 31, 2011 -6.89 Mn
Dec 31, 2011 -6.89 Mn